Intrahepatic Cholangiocarcinoma  >>  Jingzhuda (entinostat)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jingzhuda (entinostat) / EOC Pharma, EddingPharm
NCT00020579: MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Completed
1
75
US
entinostat
National Institutes of Health Clinical Center (CC), National Cancer Institute (NCI)
Cancer
04/08
10/08

Download Options